Anti-Human PAR1 (F2R) (extracellular) Antibody

Protease-activated receptor-1, PAR-1, Thrombin receptor, Coagulation factor II receptor, CF2R
    Cat #: APR-031
    Alternative Name Protease-activated receptor-1, PAR-1, Thrombin receptor, Coagulation factor II receptor, CF2R
  • Lyophilized Powder
  • Antigen Incl.
  • Type: Polyclonal
    Host: Rabbit
    Reactivity: h
    • Peptide (C)KNESGLTEYRLVSINK, corresponding to amino acid residues 61-76 of human PAR-1 (Accession P25116). Extracellular, N terminal.
    • Anti-Human PAR1 (F2R) (extracellular) Antibody
    Accession (Uniprot) Number P25116
    Gene ID 2149
    Peptide confirmation Confirmed by amino acid analysis and mass spectrometry.
    Homology Monkey - identical.
    RRID AB_2040084.
    Purity Affinity purified on immobilized antigen.
    Form Lyophilized powder. Reconstituted antibody contains phosphate buffered saline (PBS), pH 7.4, 1% BSA, 0.05% NaN3.
    Isotype Rabbit IgG.
    Specificity Unlikely to recognize mouse or rat samples.
    Storage before reconstitution The antibody ships as a lyophilized powder at room temperature. Upon arrival, it should be stored at -20°C.
    Reconstitution 25 µl, 50 μl or 0.2 ml double distilled water (DDW), depending on the sample size.
    Antibody concentration after reconstitution 0.8 mg/ml.
    Storage after reconstitution The reconstituted solution can be stored at 4°C for up to 1 week. For longer periods, small aliquots should be stored at -20°C. Avoid multiple freezing and thawing. Centrifuge all antibody preparations before use (10000 x g 5 min).
    Negative control antigen storage before reconstitution Lyophilized powder can be stored intact at room temperature for 2 weeks. For longer periods, it should be stored at -20°C.
    Negative control antigen reconstitution 100 µl double distilled water (DDW).
    Negative control antigen storage after reconstitution -20°C.
    Preadsorption Control 1 μg peptide per 1 μg antibody.
    Standard quality control of each lot Western blot analysis.
    Applications: ic, if, ifc, ih, lci, wb
    May also work in: ip*
    Western blot
    • Anti-Human PAR1 (F2R) (extracellular) Antibody
      Western blot analysis of human promyelocytic leukemia HL-60 (lanes 1 and 4), human T-cell leukemia Jurkat (lanes 2 and 5), and chronic myelogenous leukemia K562 (lanes 3 and 6) cell line lysates:
      1-3. Anti-Human PAR1 (F2R) (extracellular) Antibody (#APR-031), (1:200).
      4-6. Anti-Human PAR1 (F2R) (extracellular) Antibody, preincubated with the negative control antigen.
    • Anti-Human PAR1 (F2R) (extracellular) Antibody
      Western blot analysis of human colon cancer HT-29 (lanes 1 and 3) and Colo-205 (lanes 2 and 4) cell line lysates:
      1,2. Anti-Human PAR1 (F2R) (extracellular) Antibody (#APR-031), (1:200).
      3,4. Anti-Human PAR1 (F2R) (extracellular) Antibody, preincubated with the negative control antigen.
    • Anti-Human PAR1 (F2R) (extracellular) Antibody
      Expression of PAR-1 in normal human breast and human breast carcinoma
      Immunohistochemical staining of paraffin-embedded human breast sections using Anti-Human PAR1 (F2R) (extracellular) Antibody (#APR-031), (1:100). PAR-1 staining is highly specific for epithelium-derived cells. A. In the normal resting breast, epithelial cells of the mammary ducts are visible using Histofine (pink). B. The breast carcinoma contains epithelium-derived malignant cells stained with DAB (brown). Hematoxilin is used as the counterstain.
    Indirect flow cytometry
    • Anti-Human PAR1 (F2R) (extracellular) Antibody
      Cell surface detection of PAR-1 in live intact HL-60 (human promyelocytic leukemia) (A) and Jurkat (human T cell leukemia) (B) cell lines:
      ___ Unstained Cells + FITC-conjugated goat anti-rabbit antibody.
      ___ Cells + Anti-Human PAR1 (F2R) (extracellular) Antibody (#APR-031), (1:20) + FITC-conjugated goat anti-rabbit antibody.
    • The negative control antigen is not suitable for this application.
    Live cell imaging / Immunocytochemistry
    • Anti-Human PAR1 (F2R) (extracellular) Antibody
      Expression of PAR-1 in human prostate PC-3 cell line
      Cell surface detection of PAR-1 in human prostate PC-3 cell line. A. Live intact PC-3 cells were stained with Anti-Human PAR1 (F2R)(extracellular) Antibody (#APR-031), (1:50), followed by goat-anti-rabbit-AlexaFluor-555 secondary antibody (red staining). Nuclei were visualized using the cell-permeable dye Hoechst 33342 (blue). B. Live view of the same field as A.
    1. MacFarlane, S.R. et al. (2001) Pharmacol. Rev. 53, 245.
    2. Hollenberg, M.D. et al. (2002) Pharmacol. Rev. 54, 203.
    3. Ossovskaya, V.S. et al. (2004) Physiol. Rev. 84, 579.
    4. Arora, P. et al. (2007) J. Cell Sci. 120, 921.
    Scientific background

    Protease-activated receptor 1 (PAR-1) belongs to a family of four G protein-coupled receptors (PAR1-4) that are activated as a result of proteolytic cleavage by certain serine proteases, hence their name. In this novel modality of activation, a specific protease cleaves the PAR receptor within a defined sequence in its extracellular N-terminal domain. This results in the creation of a new N-terminal tethered ligand, which subsequently binds to a site in the second extracellular loop of the same receptor. This binding results in the coupling of the receptor to G proteins and in the activation of several signal transduction pathways.1-3

    Different PARs are activated by different proteases. Hence, PAR-1 is activated by thrombin (and is in fact also known as the thrombin receptor), as are PAR-3 and PAR-4, while PAR-2 is activated by trypsin.1-3 PAR-1 can be also cleaved and activated by other proteases such as plasmin, Factor Xa, cathepsin G, and others.

    The intramolecular nature of PAR activation and the continuous presence of the tethered ligand that cannot diffuse away imply the existence of several mechanisms for the rapid termination of PAR signaling. Indeed, following receptor activation, there is rapid phosphorylation of the C-terminal end of the receptor, followed by receptor internalization and degradation. In addition, several proteases can cleave away the tethered ligand, thereby “disarming” the PAR.1-3

    PAR-1 signals through several G proteins including Gaq, Gai, and Ga12/13, resulting in the activation of several transduction pathways including intracellular Ca2+ mobilization, Rho and Rac signaling, and MAPK activation.1-3

    PAR-1 is expressed in several cell types including platelets, leukocytes, vascular endothelial cells, gastrointestinal epithelial cells, myocytes, and neurons. The best studied physiological function of PAR-1 is its involvement in the coagulation cascade. Thrombin, the preeminent ligand of PAR-1, activates the receptor on the surface of platelets, hence inducing platelet aggregation, granular secretion, and procoagulant activity. PAR-1 also plays a crucial role in vascular ontogenesis. Accordingly, PAR-1 knockout mice show bleeding at multiple sites and usually die at mid-gestation.1-3

    PAR-1 also plays important roles in tumor growth and metastasis. PAR-1 is upregulated in several human cancers as are several proteases such as plasmin and matrix metalloproteases (MMPs) that act as PAR-1 ligands, thereby creating an autocrine loop. PAR-1 activation in cancer cells transmits mitogenic signals through the activation of the erk1/2 pathway and is involved in tumor spread via its pro-angiogenic activity.4

    Application key:

    CBE- Cell-based ELISA, FC- Flow cytometry, ICC- Immunocytochemistry, IE- Indirect ELISA, IF- Immunofluorescence, IFC- Indirect flow cytometry, IHC- Immunohistochemistry, IP- Immunoprecipitation, LCI- Live cell imaging, N- Neutralization, WB- Western blot

    Species reactivity key:

    H- Human, M- Mouse, R- Rat
    Last update: 24/01/2020

    Anti-Human PAR1 (F2R) (extracellular) Antibody (#APR-031) is a highly specific antibody directed against an epitope of human protease-activated receptor-1. The antibody can be used in western blot, immunohistochemistry, immunocytochemistry, and live cell flow cytometry applications. It has been designed to recognize PAR-1 from human samples.

    For research purposes only, not for human use



    Scientific Background


    Immunohistochemistry citations
    1. Human tendon sections (1:100).
      Christensen, J. et al. (2015) Mol. Pain 11, 13.
    Immunocytochemistry citations
    1. Human culured tenocytes (1:100).
      Christensen, J. et al. (2015) Mol. Pain 11, 13.
    Shipping and Ordering information